Hepatocellular carcinoma [11], breast cancer [12], prostate cancer [13], colorectal cancer [14], and lung cancer [15] express DKC1 at high levels, and its expression is related to disease progression and prognosis. The gene discussed is DKC1; the disease is hepatocellular carcinoma.